“"It is estimated that approximately 45% of all deaths are attributed to fibrotic pathology yet there are no FDA approved drugs available for these patients. Promedior's approach is a disruptive departure from conventional approaches. We target the scar-producing cells directly hence avoiding the biological redundancies faced by conventional therapeutic approaches.”